About Hospital Clínic i Provincial; Servicio de Hematología y Oncología
Clinical Trials at Hospital Clínic i Provincial; Servicio de Hematología y Oncología
During the past decade, Hospital Clínic i Provincial; Servicio de Hematología y Oncología conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 14 clinical trials were completed, i.e. on
average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología"
#1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Fondazione Italiana Linfomi ONLUS" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Hospital Clínic i Provincial; Servicio de Hematología y Oncología
According to Clinical.Site data, the most researched conditions in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología" are
"Breast Cancer" (3 trials), "Triple-Negative Breast Cancer" (2 trials), "Acute Myeloid Leukemia" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials) and "B-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Clínic i Provincial; Servicio de Hematología y Oncología
Most popular intervention types in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología" are "Drug" (28 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "Atezolizumab" (6 trials), "Cyclophosphamide" (5 trials), "Doxorubicin" (5 trials) and "Paclitaxel" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Clínic i Provincial; Servicio de Hematología y Oncología
The vast majority of trials in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología" are
26 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hospital Clínic i Provincial; Servicio de Hematología y Oncología
Currently, there are NaN active trials in "Hospital Clínic i Provincial; Servicio de Hematología y Oncología".
undefined are not yet recruiting,
3 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Hospital Clínic i Provincial; Servicio de Hematología y Oncología,
1 suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Clínic i Provincial; Servicio de Hematología y Oncología, 4 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".